Phase II Randomized Radiation Dose Study of Concurrent Chemoradiotherapy With S-1 Plus Nedaplatin for Esophageal Cancer
Phase 2
Recruiting
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000020075
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
a) with active gastrointestinal hemorrhage b) with clinically important infection c) with severe complicatons (heart failure, renal failure, liver failure, uncontrollable diabetes, etc.) d) with another active malignant tumors e) pregnant and/or lactating women f) judged not to understand the trial explanation g) judged to be unfit to participate in this study by investigater
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method